beta-endorphin cell therapy (Rutgers University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebeta-endorphin cell therapy (Rutgers University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRutgers University
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A